Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccinia Virus Infection”

168 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 168 results

Early research (Phase 1)Study completedNCT00428337
What this trial is testing

Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Study completedNCT00053742
What this trial is testing

Phase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine Against Smallpox

Who this might be right for
Healthy
National Institute of Allergy and Infectious Diseases (NIAID) 80
Testing effectiveness (Phase 2)Study completedNCT03206073
What this trial is testing

A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination With Immune Checkpoint Inhibition in Refractory Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaColorectal Adenocarcinoma+2 more
National Cancer Institute (NCI) 34
Early research (Phase 1)Study completedNCT03583606
What this trial is testing

A Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z)

Who this might be right for
Ebola DiseaseImmunisation
National Institute of Allergy and Infectious Diseases (NIAID) 61
Not applicableStudy completedNCT00928577
What this trial is testing

Safety Surveillance Cohort Study of Vaccinia Vaccine (ACAM2000®)

Who this might be right for
Smallpox
Emergent BioSolutions 14,108
Not applicableLooking for participantsNCT06616753
What this trial is testing

Evaluation of Patients' Knowledge of Their Vaccination Status and Their Relationship to Vaccination at Melun Hospital

Who this might be right for
Vaccinia
Groupe Hospitalier Sud Ile-de-France 140
Early research (Phase 1)UnknownNCT05684731
What this trial is testing

Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer

Who this might be right for
Ovarian Cancer
Tongji Hospital 30
Early research (Phase 1)Study completedNCT00003761
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 20
Not applicableStudy completedNCT00379678
What this trial is testing

Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
National Jewish Health 28
Testing effectiveness (Phase 2)Study completedNCT00316589
What this trial is testing

Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients

Who this might be right for
HIV Infections
Bavarian Nordic 581
Early research (Phase 1)Study completedNCT00001026
What this trial is testing

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 56
Early research (Phase 1)Study completedNCT00376090
What this trial is testing

Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults

Who this might be right for
HIV Infections
U.S. Army Medical Research and Development Command 48
Early research (Phase 1)Not Yet RecruitingNCT07170592
What this trial is testing

OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients

Who this might be right for
Treatment-Refractory Solid Tumors
Bionoxx Inc. 24
Early research (Phase 1)Study completedNCT02325050
What this trial is testing

A Safety and Immunogenicity Study of Heterologous and Homologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 164
Early research (Phase 1)Study completedNCT00079820
What this trial is testing

Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults

Who this might be right for
Smallpox
Sanofi Pasteur, a Sanofi Company 110
Large-scale testing (Phase 3)Study completedNCT02543268
What this trial is testing

Evaluate the Immunogenicity, Safety and Tolerability of Ad26.ZEBOV and MVA-BN-Filo in Healthy Adult Participants

Who this might be right for
Healthy
Crucell Holland BV 329
Large-scale testing (Phase 3)Active Not RecruitingNCT06844500
What this trial is testing

Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC

Who this might be right for
NeonateMaternal TransmissionMpox+5 more
Jean-Pierre Van geertruyden 359
Testing effectiveness (Phase 2)WithdrawnNCT02017678
What this trial is testing

Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer Origin

Who this might be right for
Ovarian Cancer
Andrea McCart
Large-scale testing (Phase 3)Looking for participantsNCT05281471
What this trial is testing

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

Who this might be right for
Platinum-resistant Ovarian CancerPlatinum-refractory Ovarian CancerFallopian Tube Cancer+4 more
Genelux Corporation 186
Early research (Phase 1)Study completedNCT00629759
What this trial is testing

Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic Carcinoma

Who this might be right for
Neoplasms, Liver
Jennerex Biotherapeutics 14
Next Page